Xencor, Inc Debt Securities, Available-for-sale, Unrealized Gain (Loss)
Xencor, Inc (XNCR) reported Debt Securities, Available-for-sale, Unrealized Gain (Loss) of -$2.00 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss · last filed 2025-02-27
- Xencor, Inc debt securities, available-for-sale, unrealized gain (loss) for the quarter ending 2024-12-31 was -$2.51M, a 228.32% decline year-over-year.
- Xencor, Inc debt securities, available-for-sale, unrealized gain (loss) for the quarter ending 2024-09-30 was $2.45M, a 113.03% increase year-over-year.
- Xencor, Inc debt securities, available-for-sale, unrealized gain (loss) for the quarter ending 2024-06-30 was -$497.00K, a 128.14% decline year-over-year.
- Xencor, Inc debt securities, available-for-sale, unrealized gain (loss) for the quarter ending 2024-03-31 was -$1.45M, a 143.43% decline year-over-year.
- Xencor, Inc debt securities, available-for-sale, unrealized gain (loss) for fiscal 2024 was -$2.00M, a 124.39% decline from fiscal 2023.
- Xencor, Inc debt securities, available-for-sale, unrealized gain (loss) for fiscal 2023 was $8.20M.
- Xencor, Inc debt securities, available-for-sale, unrealized gain (loss) for fiscal 2022 was -$5.40M.
- Xencor, Inc debt securities, available-for-sale, unrealized gain (loss) for fiscal 2021 was -$1.60M.
| Period end | Debt Securities, Available-for-sale, Unrealized Gain (Loss) 3 month | Debt Securities, Available-for-sale, Unrealized Gain (Loss) 6 month | Debt Securities, Available-for-sale, Unrealized Gain (Loss) 9 month | Debt Securities, Available-for-sale, Unrealized Gain (Loss) 12 month | Debt Securities, Available-for-sale, Unrealized Gain (Loss) 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | -$2.51M derived: 10-K 12 month − 10-Q/A 9 month · filed 2025-02-27 | -$58.00K derived: sum of 2 quarters · filed 2025-02-27 | -$555.00K derived: sum of 3 quarters · filed 2025-02-27 | -$2.00M 10-K · filed 2025-02-27 | |
| 2024-09-30 | $2.45M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2025-02-24 | $1.96M derived: sum of 2 quarters · filed 2025-02-24 | $510.00K 10-Q/A · filed 2025-02-24 | $2.47M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2024-06-30 | -$497.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2025-02-24 | -$1.94M 10-Q/A · filed 2025-02-24 | $14.00K derived: sum of 3 quarters · filed 2025-02-27 | $1.17M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2024-03-31 | -$1.45M 10-Q/A · filed 2025-02-24 | $511.00K derived: sum of 2 quarters · filed 2025-02-27 | $1.66M derived: sum of 3 quarters · filed 2025-02-27 | $3.43M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-12-31 | $1.96M derived: 10-K 12 month − 10-Q/A 9 month · filed 2025-02-27 | $3.11M derived: sum of 2 quarters · filed 2025-02-27 | $4.87M derived: sum of 3 quarters · filed 2025-02-27 | $8.20M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $1.15M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2025-02-24 | $2.92M derived: sum of 2 quarters · filed 2025-02-24 | $6.24M 10-Q/A · filed 2025-02-24 | $9.21M derived: sum of 4 quarters · filed 2025-02-24 | |
| 2023-06-30 | $1.77M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2025-02-24 | $5.09M 10-Q/A · filed 2025-02-24 | $8.06M derived: sum of 3 quarters · filed 2025-02-24 | $7.13M derived: sum of 4 quarters · filed 2025-02-24 | |
| 2023-03-31 | $3.33M 10-Q/A · filed 2025-02-24 | $6.29M derived: sum of 2 quarters · filed 2025-02-24 | $5.36M derived: sum of 3 quarters · filed 2025-02-24 | $3.54M derived: sum of 4 quarters · filed 2025-02-24 | |
| 2022-12-31 | $2.97M derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-02-24 | $2.04M derived: sum of 2 quarters · filed 2025-02-24 | $211.00K derived: sum of 3 quarters · filed 2025-02-24 | -$5.40M 10-K/A · filed 2025-02-24 | |
| 2022-09-30 | -$931.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$2.75M derived: sum of 2 quarters · filed 2023-11-08 | -$8.37M 10-Q · filed 2023-11-08 | -$9.82M derived: sum of 4 quarters · filed 2023-11-08 | |
| 2022-06-30 | -$1.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$7.43M 10-Q · filed 2023-08-03 | -$8.89M derived: sum of 3 quarters · filed 2023-08-03 | -$8.95M derived: sum of 4 quarters · filed 2023-08-03 | |
| 2022-03-31 | -$5.61M 10-Q · filed 2023-05-08 | -$7.06M derived: sum of 2 quarters · filed 2023-05-08 | -$7.12M derived: sum of 3 quarters · filed 2023-05-08 | -$7.23M derived: sum of 4 quarters · filed 2023-05-08 | |
| 2021-12-31 | -$1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | -$1.51M derived: sum of 2 quarters · filed 2023-02-27 | -$1.62M derived: sum of 3 quarters · filed 2023-02-27 | -$1.60M 10-K · filed 2023-02-27 | -$1.58M 10-K · filed 2022-02-24 |
| 2021-09-30 | -$59.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$172.00K derived: sum of 2 quarters · filed 2022-11-07 | -$149.00K 10-Q · filed 2022-11-07 | -$642.00K derived: sum of 4 quarters · filed 2022-11-07 | |
| 2021-06-30 | -$113.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | -$90.00K 10-Q · filed 2022-08-03 | -$583.00K derived: sum of 3 quarters · filed 2022-08-03 | -$1.50M derived: sum of 4 quarters · filed 2022-08-03 | |
| 2021-03-31 | $23.00K 10-Q · filed 2022-05-05 | -$470.00K derived: sum of 2 quarters · filed 2022-05-05 | -$1.39M derived: sum of 3 quarters · filed 2022-05-05 | -$959.00K derived: sum of 4 quarters · filed 2022-05-05 | |
| 2020-12-31 | -$493.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$1.41M derived: sum of 2 quarters · filed 2022-02-24 | -$982.00K derived: sum of 3 quarters · filed 2022-02-24 | -$1.09M 10-K · filed 2022-02-24 | |
| 2020-09-30 | -$916.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$489.00K derived: sum of 2 quarters · filed 2021-11-08 | -$594.00K 10-Q · filed 2021-11-08 | -$869.00K derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-06-30 | $427.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $322.00K 10-Q · filed 2021-08-04 | $47.00K derived: sum of 3 quarters · filed 2022-02-24 | -$146.00K derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-03-31 | -$105.00K 10-Q · filed 2021-05-05 | -$380.00K derived: sum of 2 quarters · filed 2022-02-24 | -$573.00K derived: sum of 3 quarters · filed 2022-02-24 | $711.00K derived: sum of 4 quarters · filed 2022-02-24 | |
| 2019-12-31 | -$275.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$468.00K derived: sum of 2 quarters · filed 2022-02-24 | $816.00K derived: sum of 3 quarters · filed 2022-02-24 | $2.13M 10-K · filed 2022-02-24 | |
| 2019-09-30 | -$193.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $1.09M derived: sum of 2 quarters · filed 2020-11-06 | $2.41M 10-Q · filed 2020-11-06 | $3.77M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2019-06-30 | $1.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $2.60M 10-Q · filed 2020-08-05 | $3.97M derived: sum of 3 quarters · filed 2021-02-24 | $3.64M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2019-03-31 | $1.32M 10-Q · filed 2020-05-08 | $2.68M derived: sum of 2 quarters · filed 2021-02-24 | $2.35M derived: sum of 3 quarters · filed 2021-02-24 | $2.55M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2018-12-31 | $1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $1.04M derived: sum of 2 quarters · filed 2021-02-24 | $1.23M derived: sum of 3 quarters · filed 2021-02-24 | $837.00K 10-K · filed 2021-02-24 | |
| 2018-09-30 | -$330.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$137.00K derived: sum of 2 quarters · filed 2019-11-05 | -$530.00K 10-Q · filed 2019-11-05 | -$1.24M derived: sum of 4 quarters · filed 2020-02-25 | |
| 2018-06-30 | $193.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$200.00K 10-Q · filed 2019-08-07 | -$911.00K derived: sum of 3 quarters · filed 2020-02-25 | ||
| 2018-03-31 | -$393.00K 10-Q · filed 2019-05-09 | -$1.10M derived: sum of 2 quarters · filed 2020-02-25 | |||
| 2017-12-31 | -$711.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$367.00K 10-K · filed 2020-02-25 | |||
| 2017-09-30 | $344.00K 10-Q · filed 2018-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |